Opendata, web and dolomites

EQUIVert SIGNED

Worldwide unique biofeedback system for non-invasive vertigo therapy and fall prevention

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 EQUIVert project word cloud

Explore the words cloud of the EQUIVert project. It provides you a very rough idea of what is the project "EQUIVert" about.

caused    inner    medicine    foreseen    guide    home    hard    sensor    gesture    registration    acoustic    ear    headphone    lifetime    personal    biofeedback    combination    market    human    individual    progress    unfortunately    balance    complete    ged    ultimately    shortcomings    symptom    16    organ    position    shortly    professional    physicians    patients    vertigo    private    compensate    people    disturbance    parallel    severe    healthcare    sensory    exercises    followed    employees    possibility    properly    dynamically    life    ease    initially    sound    conscious    equivert    ongoing    impossible    30    form    overcome    benefits    wrong    brain    give    eur    medical    accumulated    sensitivity    least    provides    dizziness    22    planning    adapts    trainer    diagnosis    training    treatment    right    options    anywhere    regarding    preinstalled    introduction    2024    turnover    until    total    central    ready    price    effectiveness    worldwide    causing    unconscious    million    train    time    once    everyday    otherwise    device    purchase    audio    anytime    expansion    huge   

Project "EQUIVert" data sheet

The following table provides information about the project.

Coordinator
GED GESELLSCHAFT FUR ELEKTRONIK UNDDESIGN MBH 

Organization address
address: PASTORATSSTRASSE 3
city: RUPPICHTEROTH
postcode: 53809
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-08-01   to  2020-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    GED GESELLSCHAFT FUR ELEKTRONIK UNDDESIGN MBH DE (RUPPICHTEROTH) coordinator 50˙000.00

Map

 Project objective

Vertigo (dizziness) is the second most common symptom in medicine, causing 30% of all people worldwide to be treated at least once in their lifetime. It is caused by a disturbance of the balance organ in our inner ear and has a significant impact on our everyday life, making many activities very hard or even impossible. However, through effective balance training, the human brain is capable to compensate for the wrong sensory information and can ultimately overcome vertigo. Unfortunately, current treatment options show severe shortcomings regarding costs, availability, and effectiveness of training. To overcome this problem, GED has developed EQUIVert. EQUIVert is the personal balance trainer for the home and professional use. It is a headphone with integrated position sensor and gesture control. It provides real-time acoustic biofeedback through sound to give the user conscious access to the otherwise unconscious combination of balance and depth sensitivity. EQUIVert is a complete system and ready to use. All exercises and training programmes are already preinstalled in the audio guide and it dynamically adapts the exercises to training progress and individual form. The major benefits for the users are the low purchase price, the effectiveness of the training, the ease of use, and the possibility to train anytime and anywhere. With over 100 million potential patients in Europe and the US, of which most are not or not properly treated right now, EQUIVert has a huge market creating potential. GED is planning a parallel market introduction, addressing private patients with an individual training device and healthcare physicians with a diagnosis support device. Following the already ongoing registration as medical device, EQUIVert will initially be introduced into the Central European market, shortly followed by an expansion across Europe and the US. A total of 22 new employees and an accumulated turnover of EUR 16 million is foreseen until the end of 2024.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EQUIVERT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EQUIVERT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

BeatsDigTherapeutics (2019)

Project SCALE: Tailored Digital Therapeutics for Neurological and Brain Disorders

Read More  

RoboSynFarm (2019)

Robotic Synthesis Farm

Read More